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Background: Cardiovascular disease and chronic kidney disease (CKD) seem to be related in a complex manner. Low density lipoprotein 
cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) are the conventional indexes of the risk for hypercholesterolemia. Patients 
with CKD have major proatherogenic lipid abnormalities that are treatable with available therapies. The LDL-C to HDL-C (L/H) ratio or non-HDL-C is 
used as the secondary benchmark of atherosclerotic disease. In this study, we compared on-treatment levels of newer and conventional markers of 
atherogenic dyslipidemia in patients with and without CKD.
Methods: We conducted a prospective cohort study that involved subjects undergoing routine health checkups at the Kyusyu Industrial Health 
Association Foundation. The study included 28,431 subjects (M: F= 14,586:13,545) between 25 and 100 years of age. We distributed the subjects 
according to their estimated GFR (eGFR) into four groups: <30, 30-59, 60-89, and ≥90 mL/min/1.73m2, based on the classification of the National 
Kidney Foundation, and subsequently by their L/H ratio into three groups: <1.5, 1.5-2.9, and ≥3.
Results: Negative correlations were found among LDL-C, L/H, and eGFR (R=-0.29, -0.22, p≤0.01). There were no significant relationships between 
non-HDL-C or HDL-C and eGFR in the whole study population. Two-way analysis of variance suggested the statistical significance of L/H ratio as 
a benchmark affecting the eGFR (p≤0.001). Moreover, multiple comparison analysis, suggested that the influence on eGFR was much greater in 
subjects with an L/H ratio<1.5 (n=6,804) than in those with an L/H ratio≥1.5 (n=21,626). Furthermore, two-way analysis of variance suggested the 
statistically significant influence of eGFR on the L/H ratio (p≤0.001) .
Conclusions: In this study, the L/H ratio was more strongly associated with eGFR than non-HDL and all other conventional lipid parameters. The 
L/H ratio was of more predictive value than non-HDL or HDL-C. The data suggested that for primary prevention of CKD the treatment target should 
be to attain an L/H ratio under 1.5.
